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Abstract
Background: Meigs’ syndrome is defined as the co-existence of benign ovarian fibroma or fibroma-like tumor,
ascites, and pleural effusion. In contrast, pseudo-Meigs’ syndrome is defined as the co-existence of other ovarian
or pelvic tumors, ascites, and pleural effusion. In Meigs’ and pseudo-Meigs’ syndromes, ascites and pleural effusion
resolve promptly after the complete resection of the ovarian or pelvic tumor(s). Secondary ovarian tumors from
colorectal gastrointestinal metastases rarely cause pseudo-Meigs’ syndrome; only 11 cases of pseudo-Meigs’
syndrome secondary to colorectal cancers have been reported in the literature. Therefore, the prognosis and
etiology of pseudo-Meigs’ syndrome caused by ovarian metastasis from colorectal cancers remain unclear.
Case presentation: We report here a rare case of pseudo-Meigs’ syndrome caused by ovarian metastases from
sigmoid colon cancer with long-term survival. A 47-year-old woman presented with abdominal distention of 1-
month duration. She developed acute dyspnea 2 weeks after the initial presentation. Colonoscopy and computed
tomography revealed sigmoid colon cancer with an ovarian metastasis, along with massive ascites and bilateral
pleural effusion. Emergency operation, including bilateral oophorectomy and sigmoidectomy, was performed.
Subsequently, ascites and bilateral pleural effusion resolved rapidly. Curative hepatic resection was performed for
liver metastases 29 months after the first operation, and as of this writing, the patient is alive with no evidence of a
disease 78 months after the first operation. In general, colorectal cancer with ovarian metastasis is hard to cure, and
long-term survival in patients with colorectal cancer with pseudo-Meigs’ syndrome is rare. Our experience suggests
that curative resection for pseudo-Meigs’ syndrome caused by ovarian metastasis from colorectal cancer may offer
long-term survival.
Conclusions: Our experience suggests that pseudo-Meigs’ syndrome can occur in a patient with colorectal cancer
after metastasis to the ovaries, causing massive ascites and pleural effusion. Aggressive treatment, including R0
resection, for this disease if allowed by the patient’s general condition may offer long-term survival.
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Background
Meigs’ syndrome is defined as the co-existence of benign
ovarian fibroma or fibroma-like tumor, ascites, and pleural
effusion [1]. The features of this disease were first de-
scribed by Meigs and Cass in 1937 [2]. In contrast,
pseudo-Meigs’ syndrome is defined as the co-existence of
other ovarian or pelvic tumors, ascites, and pleural effu-
sion [3]. In Meigs’ and pseudo-Meigs’ syndromes, ascites
and pleural effusion resolve promptly after the complete
resection of the ovarian or pelvic tumor(s) [1].
Secondary ovarian tumors from colorectal gastrointes-
tinal metastases rarely cause pseudo-Meigs’ syndrome;
only 11 cases of pseudo-Meigs’ syndrome secondary to
colorectal cancers have been reported in the literature
(Table 1) [4–10]. Therefore, the prognosis and etiology of
pseudo-Meigs’ syndrome caused by ovarian metastasis
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from colorectal cancers remain unclear. Furthermore, dif-
ferentiating between pseudo-Meigs’ syndrome and carcin-
omatous peritonitis/pleuritis as well as between ovarian
metastasis and primary ovarian cancer is often difficult.
We report here a rare case of pseudo-Meigs’ syndrome
caused by ovarian metastasis from sigmoid colon cancer,
with the patient showing long-term survival following
complete tumor resection.
Case presentation
A 47-year-old woman presented to the hospital with a
1-month history of abdominal distention. Physical
examination revealed a huge mass in the lower abdo-
men. The peripheral blood test showed elevated levels
of carcinoembryonic antigen (CEA, 335.2 ng/mL [nor-
mal, <5 ng/mL]) and carbohydrate antigen (CA) 125
(219 U/mL [normal, <45 U/mL]) but a normal level of
CA19-9 (9 U/mL [normal, <37 U/mL]). Computed
tomography (CT) demonstrated a large, round mass
with a maximum diameter of 15 cm in the pelvic cavity
without the presence of ascites or pleural effusion
(Fig. 1a, b). Colonoscopy identified an elevated lesion
with severe stenosis in the sigmoid colon, and histo-
pathological examination of biopsy specimens from the
tumor showed moderately differentiated adenocarcin-
oma. Although we scheduled an early operation, the pa-
tient developed acute dyspnea and general edema
2 weeks after the first CT scan. The second CT scan
examination demonstrated massive bilateral pleural ef-
fusion with atelectasis and ascites (Fig. 2a, b). Thoracic
drainage and laparotomy were emergently performed.
Macroscopically, the tumor in the sigmoid colon had
invaded the serosa, and the huge pelvic mass was found
to contain a right ovarian tumor. Several small nodules
of peritoneal dissemination were distributed over the
greater omentum. Perioperatively, 3800 mL of serous
ascitic fluid was drained. Cytodiagnosis of the fluid
drained from the ascites and pleural effusion revealed
no tumor cells. Bilateral oophorectomy, total hysterec-
tomy, omentectomy, and sigmoidectomy with regional
node dissection were performed (Fig. 3a). Histopathological
Table 1 Summary of reported cases of pseudo-Meigs’ syndrome resulting from ovarian metastasis of colorectal cancer














Nagakura et al. [4] 35 Metachronous None 15 Unilateral Right Yes 108 months, NED
Nagakura et al. [4] 40 Synchronous None ND Bilateral Right Yes ND
Nagakura et al. [4] 39 Synchronous None 24 Unilateral Bilateral Yes 12 months, NED
Nagakura et al. [4] 75 Synchronous Peritoneum 21 Unilateral Right No ND
Nagakura et al. [4] 53 Synchronous None 18 Bilateral Right Yes 52 months, AWD
Feldman et al. [5] 49 Metachronous None 13 Unilateral Left Yes 6 months, NED
Ohsawa et al. [6] 41 Synchronous Peritoneum 16 Bilateral Bilateral ND 9 months, dead
Rubinstein et al. [7] 61 Synchronous None 13 Bilateral Bilateral Yes ND
Okuchi et al. [8] 42 Synchronous Liver, lung 11.5 Unilateral Right No 12 months, dead
Maeda et al. [9] 58 Synchronous Peritoneum 15 Bilateral Right Yes 10 months, NED
Saito et al. [10] 44 Synchronous ND 22.8 ND Bilateral ND ND
Present case 47 Synchronous Peritoneum 18 Bilateral Bilateral Yes 78 months, NED
ND not documented, NED alive with no evidence of disease, AWD alive with disease
Fig. 1 Computed tomography demonstrated a large, round mass
with a maximum diameter of 15 cm in the pelvic cavity (a) and no
acites or pleural effusion (b)
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examination of the resected specimens showed moderately
differentiated adenocarcinoma in the tumors of both the
ovaries and the sigmoid colon (Fig. 3b). The dissected para-
colic nodes showed malignant cells. Immunohistochemi-
cally, tumor cells from the ovaries and the colon both
showed positive expression of cytokeratin 20 (CK20) but
no expression of cytokeratin 7 (CK7), confirming that the
ovarian tumors were metastases from primary colon cancer
(Fig. 4a, b). The postoperative course was uneventful, and
both pleural effusion and ascites rapidly resolved. Postoper-
atively, a regimen of 5-fluorouracil (5-FU), leucovorin, and
oxaliplatin (FOLFOX) was administered every 2 weeks for
5 months. At 29 months after the first operation, the pa-
tient required curative hepatic resection for liver metasta-
ses. At 78 months after the first operation, the patient
remains alive with no evidence of a disease.
Discussion
Our experience in this case indicated that R0 resection
may offer a good prognosis and outcomes for patients
with colorectal cancer and pseudo-Meigs’ syndrome
caused by ovarian metastases. Among such cases reported
thus far, 8 of the 12 reported patients—including our-
s—underwent R0 resection, and some showed long-term
survival [4–10]. In contrast, long-term survival was not
observed in any of the patients that did not undergo R0
resection [4–10]. In our case, bilateral oophorectomy,
omentectomy, and sigmoidectomy with regional lymph
node dissection were performed. Subsequently, hepatic
resection was performed for metachronous liver metasta-
ses, and at 78 months after the first operation, the patient
remains alive with no evidence of a disease. In general, R0
resection can be the first choice in the treatment of colo-
rectal cancer with ovarian metastasis [11]. Therefore, we
suggest that R0 resection should be performed for colo-
rectal cancer with pseudo-Meigs’ syndrome caused by
ovarian metastasis.
The differential diagnosis between pseudo-Meigs’ syn-
drome due to ovarian metastasis from colorectal cancer
and carcinomatous pleuritis/peritonitis is important, be-
cause R0 resection can be indicated for the former but not
for the latter. However, a confirmed diagnosis based on
clinical or imaging findings is rather difficult. Cytodiagno-
sis of the fluid drained from pleural effusion and ascites is
useful in the diagnosis; negative findings tend to imply
pseudo-Meigs’ syndrome, whereas positive findings imply
Fig. 2 The second computed tomographic scan, obtained 2 weeks
after the initial scan, demonstrated massive ascites (a) and bilateral
pleural effusion (b)
Fig. 3 Gross pathology. a Macroscopic findings showed a right
ovarian tumor with cystic and solid portion measuring 18 × 15 ×
11 cm. b Microscopic findings showed moderately differentiated
adenocarcinoma in both ovaries on hematoxylin and eosin staining
(magnification ×200)
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carcinomatous pleuritis or peritonitis. In our case, the
intraoperative cytodiagnosis of the ascitic and pleural
effusion fluids showed negative findings. Furthermore,
the size and number of the disseminated peritoneal
nodules were so small that they did not seem to be the
cause of the massive ascites. We therefore diagnosed
pseudo-Meigs’ syndrome and performed R0 resection.
The differential diagnosis between metastatic ovarian
cancer and primary ovarian cancer is also important, be-
cause chemotherapy regimens for colorectal cancer differ
considerably from those of ovarian cancer. The serum
level of CA125 is likely to be elevated in both primary and
metastatic ovarian cancer [12]. Immunohistochemical
staining of the resected ovarian tumor is useful for diagno-
sis; the positive expression of CK20 and no expression of
CK7 suggest metastases from colorectal cancer, whereas
the positive expression of CK7 and no expression of CK20
indicate primary ovarian cancer [13]. In our patient, we di-
agnosed the ovarian tumors as metastases from colon can-
cer based on immunohistochemical staining. Accordingly,
we administered FOLFOX as an adjuvant chemotherapy.
The details of the mechanism underlying the occur-
rence of ascites and pleural effusion in pseudo-Meigs’
syndrome remain unclear. One hypothesis is that ascites
is caused by a disparity between the arterial supply to
the ovarian tumor and its venous and lymphatic drain-
age [1, 14], and the ascites finds its way to the thoracic
cavity through intercellular gaps via aortic, esophageal,
and vena caval pathways and a number of smaller ave-
nues [15, 16]. Dye test results have shown that the
pleural effusion is likely to originate from the peritoneal
fluid via transdiaphragmatic transport [17]. This hypoth-
esis supports the fact that both ascites and pleural effu-
sion contain no malignant cells and disappear promptly
after the complete resection of the ovarian or pelvic
tumors in pseudo-Meigs’ syndrome.
Conclusions
Our experience suggests that pseudo-Meigs’ syndrome
can occur in a patient with colorectal cancer after metas-
tasis to the ovaries, causing massive ascites and pleural ef-
fusion. Aggressive treatment, including R0 resection, for
this disease if allowed by the patient’s general condition
may offer long-term survival.
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Fig. 4 Immunohistochemical findings. Immunohistochemical
staining of the ovarian tumor cells showed a positive reaction for
cytokeratin 20 (a) (magnification ×200) but no reaction for
cytokeratin 7 (b) (magnification ×200)
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